Comparison of the uptake of [123/125I]-2-iodo-D-tyrosine and [123/125I]-2-iodo-L-tyrosine in R1M rhabdomyosarcoma cells in vitro and in R1M tumor-bearing Wag/Rij rats in vivo.

[1]  N. Harada,et al.  Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  B. Cornelissen,et al.  123/125I-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: comparative uptake in various tumour types and biodistribution in mice , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  Veerle Kersemans,et al.  In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  G. Reifenberger,et al.  Evaluation of new 18F-labeled amino acids for brain PET , 2005, Anatomy and Embryology.

[5]  H. Herzog,et al.  Preferred Stereoselective Transport of the D-isomer of cis-4-[18F]fluoro-proline at the Blood–Brain Barrier , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  M. Palacín,et al.  Identification of LAT4, a Novel Amino Acid Transporter with System L Activity* , 2005, Journal of Biological Chemistry.

[7]  Veerle Kersemans,et al.  In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Emilija Veljkovic,et al.  SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  G. Slegers,et al.  Synthesis, radiosynthesis, and in vitro characterization of [125I]-2- iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT. , 2004, Nuclear medicine and biology.

[10]  S. Bröer,et al.  Molecular Cloning of Mouse Amino Acid Transport System B0, a Neutral Amino Acid Transporter Related to Hartnup Disorder* , 2004, Journal of Biological Chemistry.

[11]  E. Babu,et al.  Identification of a Novel System L Amino Acid Transporter Structurally Distinct from Heterodimeric Amino Acid Transporters* , 2003, Journal of Biological Chemistry.

[12]  Axel Bossuyt,et al.  Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  E. Babu,et al.  Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. , 2002, Biochimica et biophysica acta.

[14]  C. Meier,et al.  Activation of system L heterodimeric amino acid exchangers by intracellular substrates , 2002, The EMBO journal.

[15]  Y. Kanai,et al.  Expression of L‐type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat models , 2001, Journal of surgical oncology.

[16]  Y. Kanai,et al.  Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. , 2001, Biochimica et biophysica acta.

[17]  N. Thompson,et al.  Overexpression of LAT1/CD98 Light Chain Is Sufficient to Increase System l-Amino Acid Transport Activity in Mouse Hepatocytes but Not Fibroblasts* , 2001, The Journal of Biological Chemistry.

[18]  A. Bossuyt,et al.  In vitro characterization of the influx of 3-[125I]iodo-L-alpha-methyltyrosine and 2-[125I]iodo-L-tyrosine into U266 human myeloma cells: evidence for system T transport. , 2001, Nuclear medicine and biology.

[19]  V. Ganapathy,et al.  Cloning and functional characterization of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine. , 2000, Biochimica et biophysica acta.

[20]  M. Schwaiger,et al.  Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  Eiji Takeda,et al.  Identification and Functional Characterization of a Na+-independent Neutral Amino Acid Transporter with Broad Substrate Selectivity* , 1999, The Journal of Biological Chemistry.

[22]  Eiji Takeda,et al.  Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)* , 1998, The Journal of Biological Chemistry.

[23]  G. Digenis,et al.  Biological evaluation of radiolabeled D-methionine as a parent compound in potential nuclear imaging. , 1984, Radioisotopes.

[24]  T. Suzuki,et al.  Characteristics of D-leucine uptake by mouse Ehrlich ascites tumor cells. , 1979, Journal of biochemistry.

[25]  T. Suzuki,et al.  Preferential incorporation of some 14C-labeled D-amino acids into tumor-bearing animals. , 1978, Gan.

[26]  Veerle Kersemans,et al.  Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine. , 2006, Nuclear medicine and biology.

[27]  M. Bergström,et al.  The normal pituitary examined with positron emission tomography and (methyl-11C)-L-methionine and (methyl-11C)-D-methionine , 2004, Neuroradiology.

[28]  O. Schober,et al.  Uptake of 11C-l-and d-methionine in brain tumors , 2004, European Journal of Nuclear Medicine.

[29]  R T Borchardt,et al.  Derivatives of melphalan designed to enhance drug accumulation in cancer cells. , 1997, Journal of drug targeting.

[30]  A. Bockisch,et al.  Imaging of Brain Tumors with L-3-[123I]Iodo-α-Methyl Tyrosine and SPECT , 1989 .